What question did this study set out to answer?

The research aims to identify peptides that elicit protective IgG responses for improved allergen therapy.

March 13, 2026Clinical & Experimental Allergy0 citationsOpen Access

Patient‐Derived IgG Epitope Mapping of Bet v 1 Reveals Hypoallergenic Peptide Candidates for Safe and Next‐Generation Allergen Immunotherapy

LŠLara Šošić MPMarta Paolucci ASAlessandro Streuli

Key Points

The research aims to identify peptides that elicit protective IgG responses for improved allergen therapy.
Used patient-derived samples for epitope mapping
Identified peptides that selectively engage IgG responses
Developed a framework for allergen immunotherapy
Identified multiple hypoallergenic peptides
Peptides showed selective IgG engagement
Suggested potential for next-generation allergen immunotherapy

Abstract

This integrated approach identifies hypoallergenic peptides that selectively engage protective IgG responses and offers a framework for developing safer, next-generation immunotherapies for allergic disease.

问 AI

Bookmark

View Full Paper